Vavilis T - Search Results

1

Biopharmaceuticals against substance use disorders - Present and future.

Vavilis T, Stamoula E, Sachinidis A, Lamprinou M, Dardalas I, Papazisis G. Vavilis T, et al. Eur J Pharmacol. 2023 Apr 5;944:175587. doi: 10.1016/j.ejphar.2023.175587. Epub 2023 Feb 11. Eur J Pharmacol. 2023. PMID: 36775113 Review.

2

Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study.

Kritis AA, Stamoula EG, Paniskaki KA, Vavilis TD. Kritis AA, et al. Front Cell Neurosci. 2015 Mar 17;9:91. doi: 10.3389/fncel.2015.00091. eCollection 2015. Front Cell Neurosci. 2015. PMID: 25852482 Free PMC article. Review.

3

Oxygen-Glucose Deprivation (OGD) Modulates the Unfolded Protein Response (UPR) and Inflicts Autophagy in a PC12 Hypoxia Cell Line Model.

Vavilis T, Delivanoglou N, Aggelidou E, Stamoula E, Mellidis K, Kaidoglou A, Cheva A, Pourzitaki C, Chatzimeletiou K, Lazou A, Albani M, Kritis A. Vavilis T, et al. Cell Mol Neurobiol. 2016 Jul;36(5):701-12. doi: 10.1007/s10571-015-0250-2. Epub 2015 Aug 4. Cell Mol Neurobiol. 2016. PMID: 26239244

4

Low Dose Administration of Glutamate Triggers a Non-Apoptotic, Autophagic Response in PC12 Cells.

Stamoula E, Vavilis T, Aggelidou E, Kaidoglou A, Cheva A, Mellidis K, Lazou A, Haitoglou C, Albani M, Kritis A. Stamoula E, et al. Among authors: vavilis t. Cell Physiol Biochem. 2015;37(5):1750-8. doi: 10.1159/000430250. Epub 2015 Nov 13. Cell Physiol Biochem. 2015. PMID: 26584276 Free article.

5

mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles.

Ouranidis A, Vavilis T, Mandala E, Davidopoulou C, Stamoula E, Markopoulou CK, Karagianni A, Kachrimanis K. Ouranidis A, et al. Among authors: vavilis t. Biomedicines. 2021 Dec 27;10(1):50. doi: 10.3390/biomedicines10010050. Biomedicines. 2021. PMID: 35052730 Free PMC article. Review.

6

Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models.

Stamoula Е, Ainatzoglou A, Dardalas I, Vavilis T, Stamatellos VP, Siafis S, Psathas T, Boskou I, Papazisis G. Stamoula Е, et al. Among authors: vavilis t. CNS Neurol Disord Drug Targets. 2023;22(10):1439-1452. doi: 10.2174/1871527322666221003091444. CNS Neurol Disord Drug Targets. 2023. PMID: 36200199 Review.

7

COVID-19 vaccines adverse events: potential molecular mechanisms.

Lamprinou M, Sachinidis A, Stamoula E, Vavilis T, Papazisis G. Lamprinou M, et al. Among authors: vavilis t. Immunol Res. 2023 Jun;71(3):356-372. doi: 10.1007/s12026-023-09357-5. Epub 2023 Jan 6. Immunol Res. 2023. PMID: 36607502 Free PMC article. Review.

8

mRNA in the Context of Protein Replacement Therapy.

Vavilis T, Stamoula E, Ainatzoglou A, Sachinidis A, Lamprinou M, Dardalas I, Vizirianakis IS. Vavilis T, et al. Pharmaceutics. 2023 Jan 3;15(1):166. doi: 10.3390/pharmaceutics15010166. Pharmaceutics. 2023. PMID: 36678793 Free PMC article. Review.

9

Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS).

Stamoula E, Stamatellos VP, Vavilis T, Dardalas I, Papazisis G. Stamoula E, et al. Among authors: vavilis t. Expert Opin Drug Saf. 2024 Feb;23(2):239-245. doi: 10.1080/14740338.2023.2248873. Epub 2023 Aug 21. Expert Opin Drug Saf. 2024. PMID: 37589503

10

Assessment of the implementation of the Baby-Friendly Hospital Initiative in Greece.

Voziki E, Goulis DG, Vavilis T, Vouzas F, Bouroutzoglou M. Voziki E, et al. Among authors: vavilis t. Eur J Midwifery. 2019 Dec 19;3:23. doi: 10.18332/ejm/114936. eCollection 2019. Eur J Midwifery. 2019. PMID: 33537602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters